Mind Medicine Inc Ordinary Shares (Sub Voting) MNMD 深 滬
等待開盤 07-17 09:30:00 美东时间
8.58
+0.510
+6.32%
華盛通- 最 高8.60
- 今 開8.18
- 成交量 129.09万股
- 最 低 8.15
- 昨 收 8.07
- 總市值 6.48亿
- 52周最高 10.4362
- 市盈率 靜 --
- 換手率 1.71%
- 52周最低 4.70
- 委 比 -52.67%
- 總股本 7555.33万
- 歷史最高 86.55
- 量 比 1.08
- 振 幅 5.58%
- 歷史最低 2.20
- 每 手 1
- 風險率 0.94%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reported Earlier: 'The key to living longer could be tied to a surprising substance, study suggests'- Fox News
https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests
07-16 22:45
MindMed Issues Inducement Grants to New Employees
Mind Medicine ( ($MNMD) ) has issued an announcement. MindMed has announced the...
07-16 05:08
'Colorado Moves to Allow Hallucinogen Ibogaine for Medical Use'- Bloomberg
https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-checkout=true
06-30 23:58
"RFK Says Trump Administration Could Provide Psychedelic Therapy To Military Veterans 'Within 12 Months'" - Marijuana Moment
https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-months/
06-25 01:44
Psychedelic medicine stocks fall following Compass depression asset data
Most companies operating in the psychedelic medicine space are down significantly after Compass Pathways (NASDAQ:CMPS) on Monday posted late-stage data on its psilocybin-based treatment for treatment-...
06-24 03:24
Incannex Launches Psychedelic Therapy Clinic in Australia to Expand Mental Health Treatment Access
Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces entering into a 50:50 joint
06-17 19:36
'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment
https://www.marijuanamoment.net/doctor-seeking-to-res
06-06 22:50
Mind Medicine (MNMD) Initiated with a Buy at Oppenheimer
Mind Medicine (MNMD – Research Report) received a Buy rating and a $34.00 price...
06-02 23:45
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
05-25 04:11
